TY - JOUR
T1 - Repair of joint damage in patients with rheumatoid arthritis does not relate to previous suppression of inflammation
T2 - a subanalysis after 8 years treat-to-target in the BeSt-trial
AU - van der Pol, Joy Ardjuna
AU - Akdemir, G. lşah
AU - van den Broek, Marianne
AU - Dirven, Linda
AU - Kerstens, Pit J. S. M.
AU - Lems, Willem F.
AU - Markusse, Iris M.
AU - Huizinga, Tom W. J.
AU - Allaart, Cornelia F.
N1 - Funding Information:
The BeSt study was supported by a government grant from the Dutch College of Health Insurances, with an additional grant from Schering-Plough B.V. and Janssen B.V.
Publisher Copyright:
© 2023 BMJ Publishing Group. All rights reserved.
PY - 2023/4/25
Y1 - 2023/4/25
N2 - Objectives To investigate whether repair of erosions and joint space narrowing (JSN) in rheumatoid arthritis (RA) occurs and whether clinical variables predict this. Methods Eight-year follow-up data of the BeSt-study were used. Patients with recent onset RA (1987 criteria) were randomised to four treatment strategies and treated-to-target (Disease Activity Score (DAS)≤2.4). Yearly radiographs of hands and feet were scored in non-chronological order by four independent readers, using the Sharp/van der Heijde score (SHS). Damage repair was defined as a negative ΔSHS in an individual joint, seen by ≥3 out of 4 readers and persisting ≥2 consecutive years. Associations between repair and DAS, prednisone use, infliximab use, anticitrullinated protein antibody, gender, age, body mass index, symptom duration and randomisation arm were investigated with logistic regression analyses, corrected for mean SHS. Results Repair was seen in 17 patients (5.3%); 10 had regression of JSN, 7 of erosions, none had both. There were no significant associations in any of the regression analyses. Conclusion After 8 years of treatment to target DAS≤2.4 in 508 patients with recent onset RA, repair of JSN and erosions was seen in 17/320 patients (5.3%). Probably due to the rarity of repair, we found no associations with suppression of disease activity or other predictors and repair.
AB - Objectives To investigate whether repair of erosions and joint space narrowing (JSN) in rheumatoid arthritis (RA) occurs and whether clinical variables predict this. Methods Eight-year follow-up data of the BeSt-study were used. Patients with recent onset RA (1987 criteria) were randomised to four treatment strategies and treated-to-target (Disease Activity Score (DAS)≤2.4). Yearly radiographs of hands and feet were scored in non-chronological order by four independent readers, using the Sharp/van der Heijde score (SHS). Damage repair was defined as a negative ΔSHS in an individual joint, seen by ≥3 out of 4 readers and persisting ≥2 consecutive years. Associations between repair and DAS, prednisone use, infliximab use, anticitrullinated protein antibody, gender, age, body mass index, symptom duration and randomisation arm were investigated with logistic regression analyses, corrected for mean SHS. Results Repair was seen in 17 patients (5.3%); 10 had regression of JSN, 7 of erosions, none had both. There were no significant associations in any of the regression analyses. Conclusion After 8 years of treatment to target DAS≤2.4 in 508 patients with recent onset RA, repair of JSN and erosions was seen in 17/320 patients (5.3%). Probably due to the rarity of repair, we found no associations with suppression of disease activity or other predictors and repair.
KW - Anti-Citrullinated Protein Antibodies
KW - Antirheumatic Agents
KW - Rheumatoid Arthritis
UR - http://www.scopus.com/inward/record.url?scp=85158859891&partnerID=8YFLogxK
U2 - 10.1136/rmdopen-2023-002995
DO - 10.1136/rmdopen-2023-002995
M3 - Article
C2 - 37185308
SN - 2056-5933
VL - 9
JO - RMD Open
JF - RMD Open
IS - 2
M1 - e002995
ER -